Andson Biotech — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Andson Biotech is a private, pre-revenue platform company founded in 2016 and headquartered in Atlanta, Georgia (with a noted presence in San Diego). The company has developed the DynaChip X1, a benchtop instrument that leverages breakthrough microfluidic chip technology to automate and streamline sample preparation for mass spectrometry. This platform targets critical bottlenecks in the characterization of advanced biotherapeutics like monoclonal antibodies, ADCs, and AAVs, aiming to improve throughput, consistency, and data quality for biopharma R&D. Led by CEO and co-founder Dr. Mason Chilmonczyk, the company is backed by a board with industry and academic expertise and is focused on commercializing its tool to broaden access to high-end mass spec analysis.

Drug DeliverySmall Molecules

Technology Platform

DynaChip X1: A benchtop microfluidic platform for automated, high-throughput buffer exchange and sample preparation for mass spectrometry. Utilizes proprietary continuous-flow chip technology for rapid, consistent processing of complex biomolecules.

Opportunities

The rapid growth of complex biotherapeutics (mAbs, ADCs, AAVs) creates a strong demand for advanced analytical tools that can streamline characterization and quality control.

Andson's platform addresses the critical sample prep bottleneck in mass spectrometry, a gold-standard technique, offering a clear value proposition of speed, automation, and consistency to accelerate drug development.

Risk Factors

The company faces significant commercialization risk as a pre-revenue startup entering a competitive tools market dominated by large incumbents.

Technology adoption risk is high, as convincing laboratories to change established manual sample prep workflows requires robust validation and demonstrated ROI.

The company is also dependent on securing additional funding to scale operations and reach the market.

Competitive Landscape

Andson competes in the life science tools and mass spectrometry sample preparation market, which includes large players like Thermo Fisher Scientific, Waters Corporation, and Agilent Technologies, as well as specialized vendors offering sample prep kits and automation. Its differentiation lies in its proprietary, dedicated microfluidic hardware for rapid buffer exchange, targeting a niche for high-throughput, consistent preparation of complex therapeutic modalities.

More companies in Biologics / Biosimilars →More companies in United States →